Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization1 99 336127 036153 608188 845--
Entreprise Value (EV)1 117 650142 516167 607201 100198 087194 618
P/E ratio 285x55,2x42,2x51,5x37,9x34,3x
Yield 1,88%1,60%1,52%1,36%1,49%1,63%
Capitalization / Revenue 3,63x4,15x4,81x5,71x5,09x4,83x
EV / Revenue 4,30x4,66x5,25x6,08x5,34x4,98x
EV / EBITDA 16,8x14,5x20,5x24,1x19,2x17,1x
Price to Book 3,22x4,16x4,92x4,76x4,29x3,93x
Nbr of stocks (in thousands) 1 740 6011 756 3331 768 4561 770 530--
Reference price (USD) 57,172,386,9107107107
Last update 01/24/201801/23/201901/22/202009/11/202009/11/202009/11/2020
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales1 27 39030 57831 90433 05737 10339 070
EBITDA1 7 0229 8338 1888 34410 31811 353
Operating profit (EBIT)1 5 9766 5557 1107 2959 0219 694
Operating Margin 21,8%21,4%22,3%22,1%24,3%24,8%
Pre-Tax Profit (EBT)1 2 2312 8734 0774 0524 6595 832
Net income1 3532 3343 6873 6674 9625 473
Net margin 1,29%7,63%11,6%11,1%13,4%14,0%
EPS2 0,201,312,062,072,823,11
Dividend per Share2 1,081,161,321,451,591,74
Last update 01/24/201801/23/201901/22/202009/11/202009/11/202009/11/2020
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt1 18 31415 48013 99912 2569 2425 773
Net Cash position1 ------
Leverage (Debt / EBITDA) 2,61x1,57x1,71x1,47x0,90x0,51x
Free Cash Flow1 4 4354 9064 4984 4957 0937 783
ROE (Net Profit / Equities) 17,1%16,7%18,9%15,9%18,6%18,7%
Shareholders' equity1 2 06313 97019 54923 12926 61029 263
ROA (Net Profit / Asset) 6,83%7,16%8,60%6,93%8,11%9,05%
Assets1 5 17132 62042 85452 88161 15260 502
Book Value Per Share2 17,717,417,622,424,927,2
Cash Flow per Share2 3,183,563,453,854,98-
Capex1 1 0001 3941 6381 8021 8851 953
Capex / Sales 3,65%4,56%5,13%5,45%5,08%5,00%
Last update 01/24/201801/23/201901/22/202009/15/202009/15/202009/15/2020
1 USD in Million
2 USD
Estimates
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (USD)
188 844 729 693
Net sales (USD)
31 904 000 000
Number of employees
107 000
Sales / Employee (USD)
298 168
Free-Float
88,8%
Free-Float capitalization (USD)
167 732 791 316
Avg. Exchange 20 sessions (USD)
762 521 903
Average Daily Capital Traded
0,40%
EPS & Dividend